| Application no. and date | 20163104.1 (espacenet) (Federated) (European Patent Register), 20130621 | | Patent/reg. no. and date | DK/EP 3730136, 20231227 | | Publication date | 20201028 | | Priority no. and date | US 201261662565 P, 20120621, US 201361757229 P, 20130128, US 201361801050 P, 20130315, US 201361800618 P, 20130315 | | EP pub. no. and date |
EP 3730136 20201028 | | Effective date | | | Applicant/owner | Keryx Biopharmaceuticals, Inc., 245 First Street, Suite 1400
Cambridge, MA 02142, US | | Applicant ref. no. | P83878DK01 | | Inventor | PORADOSU, Enrique, 110 Tappan St
Brookline, MA 02445, US,
BENTSUR, Ron, 212 Highwood Avenue
Tenafly, NJ New Jersey 07670, US,
OLIVIERO III, James F., 415 Washington St.
Apt. 6C
New York, NY New York 10013, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/295 (2006.01) , A61K 9/28 (2006.01) , A61P 13/12 (2006.01) , A61P 3/00 (2006.01) , A61P 7/06 (2006.01) | | Title | ANVENDELSE AF FERRICITRAT TIL BEHANDLINGEN AF PATIENTER MED KRONISK NYRESYGDOM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
